These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26060358)

  • 1. Vitamin D Potentiates the Inhibitory Effect of MicroRNA-130a in Hepatitis C Virus Replication Independent of Type I Interferon Signaling Pathway.
    Duan X; Guan Y; Li Y; Chen S; Li S; Chen L
    Mediators Inflamm; 2015; 2015():508989. PubMed ID: 26060358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-130a inhibits HCV replication by restoring the innate immune response.
    Li S; Duan X; Li Y; Liu B; McGilvray I; Chen L
    J Viral Hepat; 2014 Feb; 21(2):121-8. PubMed ID: 24383925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.
    Duan X; Li S; Holmes JA; Tu Z; Li Y; Cai D; Liu X; Li W; Yang C; Jiao B; Schaefer EA; Fusco DN; Salloum S; Chen L; Lin W; Chung RT
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.
    Gal-Tanamy M; Bachmetov L; Ravid A; Koren R; Erman A; Tur-Kaspa R; Zemel R
    Hepatology; 2011 Nov; 54(5):1570-9. PubMed ID: 21793032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microrna-130a Downregulates HCV Replication through an atg5-Dependent Autophagy Pathway.
    Duan X; Liu X; Li W; Holmes JA; Kruger AJ; Yang C; Li Y; Xu M; Ye H; Li S; Liao X; Sheng Q; Chen D; Shao T; Cheng Z; Kaj B; Schaefer EA; Li S; Chen L; Lin W; Chung RT
    Cells; 2019 Apr; 8(4):. PubMed ID: 30974864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor and Jak-STAT signaling crosstalk results in calcitriol-mediated increase of hepatocellular response to IFN-α.
    Lange CM; Gouttenoire J; Duong FH; Morikawa K; Heim MH; Moradpour D
    J Immunol; 2014 Jun; 192(12):6037-44. PubMed ID: 24821973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A.
    Bhanja Chowdhury J; Shrivastava S; Steele R; Di Bisceglie AM; Ray R; Ray RB
    J Virol; 2012 Sep; 86(18):10221-5. PubMed ID: 22787204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-inducible Protein 6-16 (IFI-6-16, ISG16) promotes Hepatitis C virus replication in vitro.
    Chen S; Li S; Chen L
    J Med Virol; 2016 Jan; 88(1):109-14. PubMed ID: 26105982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol-analogs.
    Saleh M; Welsch C; Cai C; Döring C; Gouttenoire J; Friedrich J; Haselow K; Sarrazin C; Badenhoop K; Moradpour D; Zeuzem S; Rueschenbaum S; Lange CM
    J Steroid Biochem Mol Biol; 2018 Oct; 183():142-151. PubMed ID: 29885880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
    Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the roles of the 5' exoribonucleases Xrn1 and Xrn2 in restricting hepatitis C virus replication.
    Li Y; Yamane D; Lemon SM
    J Virol; 2015 May; 89(9):4857-65. PubMed ID: 25673723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antiviral activity of human interferon combinations in the hepatitis C virus replicon system.
    Larkin J; Jin L; Farmen M; Venable D; Huang Y; Tan SL; Glass JI
    J Interferon Cytokine Res; 2003 May; 23(5):247-57. PubMed ID: 12804067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a recombinant reporter hepatitis C virus useful for the analyses of virus entry, intra-cellular replication and virion production.
    Kamada K; Shoji I; Deng L; Aoki C; Ratnoglik SL; Wakita T; Hotta H
    Microbes Infect; 2012 Jan; 14(1):69-78. PubMed ID: 21917232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1α and PPARγ.
    Huang JY; Chou SF; Lee JW; Chen HL; Chen CM; Tao MH; Shih C
    RNA; 2015 Mar; 21(3):385-400. PubMed ID: 25595716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
    Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.